Patent · US Active

Anti-idiotypic antibodies against anti-GPRC5D antibodies

US12030937B2 · kind B2 · utility

0Cited by
4References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 15, 2021
Grant dateJul 9, 2024
Priority date
Expiry dateJan 13, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/705
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

In certain aspects, the disclosure relates to anti-idiotype antibodies and antigen-binding portions thereof that specifically bind a GP5B83 containing protein, e.g., an antibody or antigen-binding portions thereof. In some aspects, the anti-idiotype antibodies and antigen-binding portions of the present disclosure can be used in methods to detect and quantify cells expressing chimeric antigen receptors that include GP5B83.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.